Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways.
Cammisotto V, Baratta F, Castellani V, Bartimoccia S, Nocella C, D'Erasmo L, Cocomello N, Barale C, Scicali R, Di Pino A, Piro S, Del Ben M, Arca M, Russo I, Purrello F, Carnevale R, Violi F, Pastori D, Pignatelli P.
Cammisotto V, et al. Among authors: del ben m.
Int J Mol Sci. 2021 Jul 3;22(13):7193. doi: 10.3390/ijms22137193.
Int J Mol Sci. 2021.
PMID: 34281247
Free PMC article.